Badran Hala Mahfouz, Soltan Ghada, Almeleigi Reda, Faheem Naglaa, Yacoub Magdi H
Cardiology Department, Menoufia University, Tanta, Egypt.
The BAHCM National Program, Tanta, Egypt.
Echocardiography. 2019 Dec;36(12):2167-2175. doi: 10.1111/echo.14539. Epub 2019 Nov 19.
Left ventricular (LV) diastolic dysfunction is a prominent feature of hypertrophic cardiomyopathy (HCM). Prediction of LV filling pressure using the ratio between early diastolic transmitral flow and mitral annular velocity (E/e') had proved a good accuracy.
We investigated the value of E/e' to predict cardiovascular (CV) mortality in patients with HCM.
A total of 243 patients with HCM had E/e' measured in combination with clinical evaluation, conventional echocardiographic measurements, cardiopulmonary exercise evaluation, and Holter monitoring.
During a mean follow-up of (3.2 ± 1.2 years), 17 (7%) patients died. Non survivors had significantly higher SBP, DBP, left ventricular outflow tract obstruction (LVOTO) gradient, mitral E, and E/e', but lower e' of mitral annulus and more prevalent restrictive filling pattern. E/e' was directly correlated with age (r = .24, P < .005), left atrial volume index (r = .44, P < .0001), LVMI (r=0.23,P<.005), LVOT gradient (r = .43, P < .0001), NYHA class (r = .19, P < .006), pulmonary artery pressure (r = .24, P < .005), positive family history of HCM (r = .22, P < .005), and inversely related to peak systolic velocity (S) (r = .44, P < .0001). By multivariate analysis, only LVOTO ([RR] 4.11, 95% CI 1.002 to 1.148, P < .04) and E/e' were independent predictors for overall mortality in HCM (relative risk [RR] 5.27, 95% CI 1.002 to 1.024, P < .02). The risk of dying increased with increasing E/e' ratio, being approximately 4 times higher for patients in the highest quartile (HR 3.8 (CI 1.38-5.12, log-rank < 0.002)).
In hypertrophic cardiomyopathy, the E/e' ratio remains a powerful predictor of all-cause mortality, particularly if it is associated with LVOT obstruction.
左心室舒张功能障碍是肥厚型心肌病(HCM)的一个突出特征。利用舒张早期二尖瓣血流与二尖瓣环速度之比(E/e')预测左心室充盈压已被证明具有良好的准确性。
我们调查了E/e'对预测HCM患者心血管(CV)死亡率的价值。
总共243例HCM患者接受了E/e'测量,并结合临床评估、传统超声心动图测量、心肺运动评估和动态心电图监测。
在平均随访(3.2±1.2年)期间,17例(7%)患者死亡。非存活者的收缩压、舒张压、左心室流出道梗阻(LVOTO)压差、二尖瓣E峰和E/e'显著更高,但二尖瓣环e'更低,且限制性充盈模式更普遍。E/e'与年龄直接相关(r = 0.24,P < 0.005)、左心房容积指数(r = 0.44,P < 0.0001)、左心室质量指数(r = 0.23,P < 0.005)、LVOT压差(r = 0.43,P < 0.0001)、纽约心脏协会(NYHA)心功能分级(r = 0.19,P < 0.006)、肺动脉压(r = 0.24,P < 0.005)、HCM家族史阳性(r = 0.22,P < 0.005),并与收缩期峰值速度(S)呈负相关(r = 0.44,P < 0.0001)。通过多因素分析,仅LVOTO(相对风险[RR] 4.11,95%可信区间1.002至1.148,P < 0.04)和E/e'是HCM总体死亡率的独立预测因素(相对风险[RR] 5.27,95%可信区间1.002至1.024,P < 0.02)。随着E/e'比值增加,死亡风险升高,最高四分位数患者的死亡风险约高4倍(风险比3.8(可信区间1.38 - 5.12,对数秩检验< 0.002))。
在肥厚型心肌病中,E/e'比值仍然是全因死亡率的有力预测指标,特别是当它与LVOT梗阻相关时。